Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Polaryx Therapeutics(PLYX) the EBIT is -1.38 M (--%), Beat estimate;the EPS is -0.03 (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.00B--
-0.00B--
+0.00B--%
EPSExceed expectations
-0.03--
-0.04--
+0.0100--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf